Nichi-Iko Pharmaceutical Co., Ltd.

Text Size

S
M
L

Japanese
English

COMPANYAbout Us

GENERICProduct Information

CORPORATE SOCIAL RESPONSIBILITYCSR

POLICYMission

POLICYQuolity Policy

INFORMATION

- 12/12/2024
  
  PRESS RELEASE
  
  Nichi-Iko and Fujitsu drive pharmaceutical manufacturing DX with AI
- 02/28/2023
  
  PRESS RELEASE
  
  Notice Regarding Change in the Company's Consolidated Subsidiary
- 02/13/2023
  
  PRESS RELEASE
  
  Extraordinary General Meeting of Shareholders Notice of Convocation
- 01/25/2023
  
  PRESS RELEASE
  
  Notice Regarding Convocation of the Extraordinary General Meeting of Shareholders and Decision on Agenda Proposals, Capital Reduction, Appropriation of Surplus, Change in Representative Board Member, and Officer Appointments
- 12/29/2022
  
  PRESS RELEASE
  
  Notice Regarding Convening of Creditors' Meeting for Resolution of Proposed Business Turnaround Plan in Business Turnaround ADR, Completion of Business Turnaround ADR, and Financial Support including Debt Forgiveness